Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

7.4K
Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
7.4K
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

8.9K
The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
8.9K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

4.2K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Interfacial Microenvironment Effects on the Mechanism of Photocatalytic Methanol Conversion for Hydrogen Evolution.

The journal of physical chemistry letters·2026
Same author

BMX-001 acts as a selective chemoradioprotector in rectal cancer.

Redox biochemistry and chemistry·2026
Same author

Effect of Black Rice Starch on Structure and Physical-Mechanical Properties of Carboxymethyl Chitosan/Gellan Gum-Based Intelligent Food Packaging Film and Application in Monitoring Shrimp Freshness.

Polymers·2026
Same author

Procedures to Verify Legitimacy and Uniqueness of Responses in an Online Study with U.S. Young Gay and Bisexual Men Who Use Stimulants.

AIDS and behavior·2026
Same author

Molecular classification and association with survival outcomes in high-intermediate and high-risk early-stage endometrial cancers: Ancillary analysis of GOG-0249.

Gynecologic oncology·2026
Same author

Doing Good Well in Unethical Times: A Call to Action for HIV Prevention Research.

AIDS and behavior·2026

Related Experiment Video

Updated: Sep 12, 2025

Comparing Metastatic Clear Cell Renal Cell Carcinoma Model Established in Mouse Kidney and on Chicken Chorioallantoic Membrane
05:36

Comparing Metastatic Clear Cell Renal Cell Carcinoma Model Established in Mouse Kidney and on Chicken Chorioallantoic Membrane

Published on: February 8, 2020

9.1K

Wilms Tumor, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology.

Frank Balis1, Daniel M Green2, Amy Armstrong3

  • 11Abramson Cancer Center at the University of Pennsylvania.

Journal of the National Comprehensive Cancer Network : JNCCN
|August 5, 2025
PubMed
Summary

The NCCN Guidelines provide updated recommendations for diagnosing and treating Wilms tumor (nephroblastoma) in children. Management strategies aim to improve survival rates for all Wilms tumor types while minimizing treatment side effects.

More Related Videos

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1.2K
Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
07:29

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Published on: April 22, 2019

11.6K

Related Experiment Videos

Last Updated: Sep 12, 2025

Comparing Metastatic Clear Cell Renal Cell Carcinoma Model Established in Mouse Kidney and on Chicken Chorioallantoic Membrane
05:36

Comparing Metastatic Clear Cell Renal Cell Carcinoma Model Established in Mouse Kidney and on Chicken Chorioallantoic Membrane

Published on: February 8, 2020

9.1K
Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1.2K
Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
07:29

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Published on: April 22, 2019

11.6K

Area of Science:

  • Pediatric Oncology
  • Clinical Practice Guidelines
  • Nephroblastoma Research

Background:

  • Wilms tumor (nephroblastoma) is the most common pediatric kidney cancer.
  • Histology (favorable vs. anaplastic) significantly impacts prognosis.
  • Current treatment protocols aim for high cure rates and reduced long-term toxicities.

Purpose of the Study:

  • To present the NCCN Clinical Practice Guidelines for Wilms tumor management.
  • To outline screening, diagnosis, and treatment strategies.
  • To cover recommendations for both favorable and anaplastic histology Wilms tumors.

Main Methods:

  • Guideline development by the NCCN panel.
  • Review of current evidence for Wilms tumor treatment.
  • Synthesis of recommendations for clinical practice.

Main Results:

  • Guidelines address unilateral and bilateral Wilms tumors.
  • Treatment varies based on histology, stage, and laterality.
  • High survival rates are achievable with appropriate treatment for favorable histology.

Conclusions:

  • Adherence to NCCN Guidelines is crucial for optimal Wilms tumor outcomes.
  • Personalized treatment approaches are essential.
  • Minimizing long-term toxicities remains a key therapeutic goal.